Is Cannabis / THC legal in Guyana?

Also known as: weed, marijuana

Legal status

Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «cannabis; resina DE cannabis; tetrahidrocannabinol», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The entry covers three things at once: the plant, the resin and the statutory tetrahydrocannabinol wording. They are read as printed and are not collapsed into cannabidiol, which this corpus checks on its own row and which the dossier does not prove as a named entry. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.

Consequences if caught

Capital exposure: none. Guyana's Cap. 10:10 carries no death penalty at any tier; section 5(1) sets the indictable trafficking ceiling at life imprisonment, so the worst outcome this Act reaches is a life sentence. This row also carries the one quantity rule the dossier records anywhere in Guyana: possession of 30 g or less of cannabis has no imprisonment under the 2022 amendment. Above that line the ordinary route returns and the section 5(1) trafficking ceiling is life. The dossier gives the 30 g figure and the 2022 amendment and nothing further, so no counselling scheme, community service band, fine figure or intermediate tier is asserted here, and the live cell's figures for those tiers are not carried forward. Identification still runs to the printed entry: the plant, the resin and the statutory tetrahydrocannabinol wording are three separate things, so the 30 g rule is a rule about cannabis in possession and does not transfer of its own force to a resin or to a concentrate. [Likely] Carried forward from the published entry and not re-derived from statute in this pass: Cannabis is controlled in Guyana under the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap 10:10, but the 2021 amendment removed custodial sentences for small quantities. In Guyana, drugs fall under the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap 10:10 (Act No. 2 of 1988, as amended through 2021). Possession (s.4) carries a fine of not less than G$30,000 or three times the market value of the narcotic, together with imprisonment of 3-5 years. Trafficking (s.5) is punished more heavily; the exact statutory maximum for trafficking is not pinned in the cited source and is not assumed here, verify the s.5 penalty. A 2021 reform, the Narcotic Drugs and Psychotropic Substances (Control) (Amendment) Act No. 2 of 2021, in force 2022, removed custodial sentences for small cannabis quantities: possession of up to 15 g of cannabis now draws mandatory counselling, and up to 30 g draws community service of up to 6 months, rather than imprisonment. Larger amounts and all trafficking remain criminal.

If prescribed or medical

Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «cannabis; resina DE cannabis; tetrahidrocannabinol» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Cannabis is dispensed as a medicine in some countries and the dossier records no Guyanese medical cannabis route at all, so the 30 g possession rule is not a medical permission and must not be read as one. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.

Documentation

The 30 g line is about quantity in possession and not about paperwork, so no document enlarges it. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «cannabis; resina DE cannabis; tetrahidrocannabinol».

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Guyana’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.